April 7, 2014 — In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular ...
April 07, 2014
April 2, 2014 — Statins are associated with a significant improvement in erectile function, a fact researchers hope will ...
April 02, 2014
March 25, 2014 – As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind ...
March 25, 2014March 25, 2014 — Patient enrollment has been completed four months ahead of plan in the Phase III clinical trial EUCLID ...
March 25, 2014
March 18, 2014 — Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from ...
March 18, 2014March 12, 2014 — Janssen Research and Development LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) ...
March 12, 2014February 27, 2014 — Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk ...
February 27, 2014
February 7, 2014 — Results from several late-breaking clinical trials will be presented during the American College of ...
February 07, 2014February 3, 2014 — A large-scale analysis assessing the real-world risk of venous thromboembolism (VTE) in chemotherapy ...
February 03, 2014January 22, 2014 — The U.S. Food and Drug Administration (FDA)’s Cardiovascular and Renal Drugs Advisory Committee ...
January 22, 2014January 22, 2014 — The U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted ...
January 22, 2014January 14, 2014 — Daiichi Sankyo Company Ltd. announced results from the Phase 3 ENGAGE AF-TIMI 48 study [1]. The ...
January 14, 2014
December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
December 24, 2013December 23, 2013 — Careful documentation of patient selection and procedure appropriateness are critical — yet ...
December 23, 2013